Loading...
Evolus, Inc.
EOLS•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$9.53
$-0.12(-1.24%)
Evolus, Inc. (EOLS) Financial Performance & Income Statement Overview
Review Evolus, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
31.76%
↑ 31.76%
Operating Income Growth
30.11%
↑ 30.11%
Net Income Growth
18.26%
↑ 18.26%
Operating Cash Flow Growth
47.07%
↑ 47.07%
Operating Margin
-14.20%
↓ 14.20%
Gross Margin
67.73%
↑ 67.73%
Net Profit Margin
-20.44%
↓ 20.44%
ROE
-931.98%
↓ 931.98%
ROIC
-24.86%
↓ 24.86%
Evolus, Inc. (EOLS) Income Statement & Financial Overview
Review Evolus, Inc.'s (EOLS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $78.95M | $61.09M | $66.91M | $59.33M |
| Cost of Revenue | $28.60M | $18.22M | $20.50M | $19.48M |
| Gross Profit | $50.34M | $42.86M | $46.41M | $39.86M |
| Gross Profit Ratio | $0.64 | $0.70 | $0.69 | $0.67 |
| R&D Expenses | $2.43M | $2.31M | $2.35M | $2.08M |
| SG&A Expenses | $50.24M | $52.51M | $50.15M | $45.12M |
| Operating Expenses | $52.67M | $58.34M | $52.50M | $47.20M |
| Total Costs & Expenses | $79.00M | $76.56M | $73.006M | $66.68M |
| Interest Income | $789000.00 | $928000.00 | $1.03M | $517000.00 |
| Interest Expense | $4.57M | $4.76M | $4.70M | $4.70M |
| Depreciation & Amortization | $1.61M | $1.27M | $1.43M | $1.56M |
| EBITDA | -$3.12M | -$22.71M | -$5.18M | -$6.80M |
| EBITDA Ratio | -$0.04 | -$0.37 | -$0.08 | -$0.11 |
| Operating Income | -$2.31M | -$15.47M | -$6.10M | -$7.34M |
| Operating Income Ratio | -$0.03 | -$0.25 | -$0.09 | -$0.12 |
| Other Income/Expenses (Net) | -$4.04M | -$3.56M | -$3.60M | -$4.14M |
| Income Before Tax | -$6.35M | -$19.04M | -$11.31M | -$13.06M |
| Income Before Tax Ratio | -$0.08 | -$0.31 | -$0.17 | -$0.22 |
| Income Tax Expense | $440000.00 | $134000.00 | $43000.00 | $47000.00 |
| Net Income | -$6.79M | -$19.17M | -$11.35M | -$13.11M |
| Net Income Ratio | -$0.09 | -$0.31 | -$0.17 | -$0.22 |
| EPS | -$0.11 | -$0.30 | -$0.18 | -$0.22 |
| Diluted EPS | -$0.11 | -$0.30 | -$0.18 | -$0.22 |
| Weighted Avg Shares Outstanding | $61.74M | $63.15M | $62.72M | $58.80M |
| Weighted Avg Shares Outstanding (Diluted) | $63.37M | $63.15M | $62.72M | $58.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan